These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 36969833)
1. Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis. Zhou Q; Liu X; Yang X; Huang XH; Wu YZ; Tao YY; Wei M Front Pharmacol; 2023; 14():1122564. PubMed ID: 36969833 [No Abstract] [Full Text] [Related]
2. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex. Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB; Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309 [TBL] [Abstract][Full Text] [Related]
3. Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four Liu F; Wang Y; Luo J; Huang L; Zhu W; Yin K; Xue Z Front Cardiovasc Med; 2022; 9():841341. PubMed ID: 35310968 [TBL] [Abstract][Full Text] [Related]
4. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis. Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242 [TBL] [Abstract][Full Text] [Related]
5. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage. Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848 [TBL] [Abstract][Full Text] [Related]
6. Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage. Liu X; Guo S; Xu Z Front Cardiovasc Med; 2022; 9():961000. PubMed ID: 35911529 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628 [TBL] [Abstract][Full Text] [Related]
8. Effect of oral anticoagulation therapy in atrial fibrillation patients with a history of intracranial hemorrhage: a systematic review and meta-analysis. Liu M; Hou Y; Liu W; Liu M Ann Palliat Med; 2022 Oct; 11(10):3063-3074. PubMed ID: 35948473 [TBL] [Abstract][Full Text] [Related]
9. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081 [TBL] [Abstract][Full Text] [Related]
10. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation. Nielsen PB; Larsen TB; Skjøth F; Lip GY JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151 [TBL] [Abstract][Full Text] [Related]
11. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials. Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948 [TBL] [Abstract][Full Text] [Related]
12. Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage. Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH Stroke; 2020 Feb; 51(2):416-423. PubMed ID: 31813363 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis. See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254 [TBL] [Abstract][Full Text] [Related]
14. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials. Al-Shahi Salman R; Stephen J; Tierney JF; Lewis SC; Newby DE; Parry-Jones AR; White PM; Connolly SJ; Benavente OR; Dowlatshahi D; Cordonnier C; Viscoli CM; Sheth KN; Kamel H; Veltkamp R; Larsen KT; Hofmeijer J; Kerkhoff H; Schreuder FHBM; Shoamanesh A; Klijn CJM; van der Worp HB; Lancet Neurol; 2023 Dec; 22(12):1140-1149. PubMed ID: 37839434 [TBL] [Abstract][Full Text] [Related]
15. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis. Harel Z; Chertow GM; Shah PS; Harel S; Dorian P; Yan AT; Saposnik G; Sood MM; Molnar AO; Perl J; Wald RM; Silver S; Wald R Can J Cardiol; 2017 Jun; 33(6):737-746. PubMed ID: 28545622 [TBL] [Abstract][Full Text] [Related]
16. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation. Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320 [TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Meta-Analysis: Can We Compare Direct Oral Anticoagulants to Warfarin in Patients With Atrial Fibrillation and Bio-Prosthetic Valves? Adhikari G; Baral N; Rauniyar R; Karki S; Abdelazeem B; Savarapu P; Isa S; Khan HMW; Khan MR; Changezi HU Cureus; 2021 Apr; 13(4):e14651. PubMed ID: 34046282 [TBL] [Abstract][Full Text] [Related]
18. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K; Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016. Newman TV; Chen N; He M; Saba S; Hernandez I Am J Cardiovasc Drugs; 2020 Oct; 20(5):471-479. PubMed ID: 31808136 [TBL] [Abstract][Full Text] [Related]
20. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data. Hu W; Cai H; Zhang J Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]